Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CEST
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
02/15 PHOTOCURE ASA : Results for fourth quarter and full year 2016
02/08 PHOTOCURE : A better future for patients with bladder cancer using advanced tech..
02/07 PHOTOCURE ASA : Presentation of the fourth quarter and full year 2016 results
02/03 PHOTOCURE : Completes Enrollment in US Market expansion study of Blue Light Flex..
01/23 PHOTOCURE ASA : Chairperson Bente-Lill Romøren not candidate for re-election
01/09 PHOTOCURE : to present at investor meetings in San Francisco
2016 PCI BIOTECH : PCIB - Disclosure of large shareholding
2016 PHOTOCURE : US registry shows that Blue Light Cystoscopy (BLC) with Cysview®/Hex..
2016 PHOTOCURE ASA : Share capital increase registered
2016 PHOTOCURE ASA : Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® decreases the ..
More news
Sector news : Pharmaceuticals - NEC
03/29 FDA, Mylan silence on generic Advair may be good news for GSK
03/29 British business navigates rocky path to Brexit
03/29 ConvaTec's majority investors raise $1.2 billion via stake sale
03/28DJSenator McCaskill Begins Probe of Prescription Opioid Marketing -- 2nd Update
03/28DJSHIRE : Files 8K - Other Events
More sector news : Pharmaceuticals - NEC
Advertisement
Financials ( NOK)
Sales 2017 150 M
EBIT 2017 -1,58 M
Net income 2017 -29,6 M
Finance 2017 119 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 4,17x
EV / Sales 2018 3,01x
Capitalization 746 M
More Financials
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 46,0  NOK
Spread / Average Target 33%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Bente-Lill B. Romøren Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-18.33%88
JOHNSON & JOHNSON9.07%338 645
ROCHE HOLDING LTD.8.81%221 440
PFIZER INC.5.70%204 439
NOVARTIS AG-0.47%197 239
MERCK & CO., INC.8.10%174 728
More Results